Abiopharma

Integer Holdings Corporation - Integer Announces Strategic Review to Maximize Stockholder Value

BioReference® Launches BioReferenceDirect™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

Ceased to serve as a director - Shlomo Gutman as of 1.5.26

Mastercard Incorporated First Quarter 2026 Financial Results Available on Company’s Website

Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems

BRC Group Holdings, Inc. Announces First Quarter 2026 Earnings Call

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Halozyme - Halozyme Appoints Darren Snellgrove as Chief Financial Officer

Natera - Natera to Report its First Quarter Results on May 7, 2026

Ceased to serve as a director - Amir Biram as of 1.5.26